CHIMERIX, INC.

ACTIVE

5015 Southpark Dr Ste 240, 北卡罗来纳州达勒姆县, 北卡罗来纳州, United Stateswww.chimerix.comPublic72 employeesEstablished: 2002-01-01

Clinical Trials

12 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2002

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

90.5%

Phase 2

4.8%

Trial Status Distribution

Active, not recruiting

52.4%

Completed

28.6%

Not yet recruiting

4.8%

Recruiting

9.5%

Withdrawn

4.8%

Clinical Trials

Trials sponsored by this organization (21)

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (The ACTION Study)

Recruiting

interventional

12 participants

An Open-label, Randomized, Multi-center, Parallel Group, Two-arm Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir versus Standard of Care for Treatment of Adenovirus Infections in High-risk Pediatric Allogeneic Hematopoietic Cell Transplant Recipients

Investigating the safety and tolerability of ONC201 in healthy adults under fasting and fed conditions - Part 2b

Phase 1

Completed

interventional

Jul 202130 participants

Investigating the safety and tolerability of ONC201 in healthy adults under fasting and fed conditions

Phase 1

Completed

interventional

Jul 202118 participants

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations

CHIMERIX, INC.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (21)

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (The ACTION Study)

An Open-label, Randomized, Multi-center, Parallel Group, Two-arm Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir versus Standard of Care for Treatment of Adenovirus Infections in High-risk Pediatric Allogeneic Hematopoietic Cell Transplant Recipients

Effect of ONC201 on Cardiac Repolarization in Healthy Participants - Part 2

Effect of ONC201 on Cardiac Repolarization in Healthy Participants - Part 1

Effect of ONC201 on participants with renal impairment

Investigating the safety and tolerability of ONC201 in healthy adults - Part A

Investigating the safety and tolerability of ONC201 in healthy adults under fasting and fed conditions - Part 2b

Investigating the safety and tolerability of ONC201 in healthy adults under fasting and fed conditions

Approvals

Approvals by Agency

Recent Approvals

News